KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $35,728,000 | -73.8% | 198,700 | -84.9% | 0.04% | -76.4% |
| Q2 2017 | $136,243,000 | +32.1% | 1,314,200 | 0.0% | 0.18% | +30.0% |
| Q1 2017 | $103,152,000 | +75.0% | 1,314,200 | 0.0% | 0.14% | +64.7% |
| Q4 2016 | $58,929,000 | -19.7% | 1,314,200 | 0.0% | 0.08% | -19.8% |
| Q3 2016 | $73,411,000 | +102.6% | 1,314,200 | +81.3% | 0.11% | +100.0% |
| Q2 2016 | $36,235,000 | +8.9% | 724,700 | 0.0% | 0.05% | +3.9% |
| Q1 2016 | $33,271,000 | -25.5% | 724,700 | 0.0% | 0.05% | -26.1% |
| Q4 2015 | $44,656,000 | +10.7% | 724,700 | 0.0% | 0.07% | -5.5% |
| Q3 2015 | $40,351,000 | -8.7% | 724,700 | 0.0% | 0.07% | -2.7% |
| Q2 2015 | $44,185,000 | +5.7% | 724,700 | 0.0% | 0.08% | -1.3% |
| Q1 2015 | $41,801,000 | +0.0% | 724,700 | 0.0% | 0.08% | -11.6% |
| Q4 2014 | $41,793,000 | – | 724,700 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
| BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
| NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
| Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
| SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
| ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
| BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |